{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T01:25:17Z","timestamp":1777685117457,"version":"3.51.4"},"reference-count":79,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2019,8,27]]},"DOI":"10.3233\/jhd-180301","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T13:10:22Z","timestamp":1561727422000},"page":"271-289","source":"Crossref","is-referenced-by-count":2,"title":["Differential Levels and Phosphorylation of Type 1 Inositol 1,4,5-Trisphosphate Receptor in Four Different Murine Models of Huntington Disease"],"prefix":"10.1177","volume":"8","author":[{"given":"Joakim Iver","family":"Post","sequence":"first","affiliation":[{"name":"The Biotechnology Centre of Oslo, University of Oslo, Oslo, Norway"},{"name":"Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trygve B.","family":"Leergaard","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"Ratz","sequence":"additional","affiliation":[{"name":"Department for Experimental Therapy, Preclinical Experimental Centre, Friedrich-Alexander-University Erlangen-N\u00fcrnberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Ivar","family":"Walaas","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"von H\u00f6rsten","sequence":"additional","affiliation":[{"name":"Department for Experimental Therapy, Preclinical Experimental Centre, Friedrich-Alexander-University Erlangen-N\u00fcrnberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lise Sofie H.","family":"Nissen-Meyer","sequence":"additional","affiliation":[{"name":"The Biotechnology Centre of Oslo, University of Oslo, Oslo, Norway"},{"name":"Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway"},{"name":"Department of Immunology and Transfusion, Oslo University Hospital, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"issue":"6410","key":"10.3233\/JHD-180301_ref1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/361315a0","article-title":"Inositol trisphosphate and calcium signalling","author":"Berridge","year":"1993","journal-title":"Nature"},{"issue":"3-4","key":"10.3233\/JHD-180301_ref2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ceca.2005.06.030","article-title":"The inositol 1,4,5-trisphosphate receptors","volume":"38","author":"Bezprozvanny","year":"2005","journal-title":"Cell Calcium"},{"issue":"5","key":"10.3233\/JHD-180301_ref3","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1471-4159.2007.04825.x","article-title":"IP3 receptor\/Ca2+ channel: From discovery to new signaling concepts","volume":"102","author":"Mikoshiba","year":"2007","journal-title":"J Neurochem"},{"key":"10.3233\/JHD-180301_ref4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-94-007-2888-2_11","article-title":"Inositol 1,4,5-trisphosphate and its receptors","volume":"740","author":"Parys","year":"2012","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"10.3233\/JHD-180301_ref5","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tins.2008.06.005","article-title":"Neuronal calcium mishandling and the pathogenesis of Alzheimer\u2019s disease","volume":"31","author":"Bezprozvanny","year":"2008","journal-title":"Trends Neurosci"},{"issue":"2","key":"10.3233\/JHD-180301_ref6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/neur.1996.0024","article-title":"Decreased inositol (1,4,5)-trisphosphate receptor levels in Alzheimer\u2019s disease cerebral cortex: Selectivity of changes and possible correlation to pathological severity","volume":"5","author":"Haug","year":"1996","journal-title":"Neurodegeneration"},{"issue":"1-2","key":"10.3233\/JHD-180301_ref7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0006-8993(98)00347-3","article-title":"Loss of inositol 1,4,5-trisphosphate receptor sites and decreased PKC levels correlate with staging of Alzheimer\u2019s disease neurofibrillary pathology","volume":"796","author":"Kurumatani","year":"1998","journal-title":"Brain Res"},{"issue":"2","key":"10.3233\/JHD-180301_ref8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0006-8993(91)90436-Y","article-title":"Modification of [3H]inositoltrisphosphate binding in kainic acid- lesioned and postischemic rat hippocampus","volume":"538","author":"J\u00f8rgensen","year":"1991","journal-title":"Brain Res"},{"issue":"2","key":"10.3233\/JHD-180301_ref9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0306-4522(00)00470-X","article-title":"Differential neuronal localizations and dynamics of phosphorylated and unphosphorylated type 1 inositol 1,4,5-trisphosphate receptors","volume":"102","author":"Pieper","year":"2001","journal-title":"Neuroscience"},{"issue":"4-5","key":"10.3233\/JHD-180301_ref10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0197-0186(99)00129-1","article-title":"Reduced [3H]IP3 binding but unchanged IP3 receptor levels in the rat hippocampus CA1 region following transient global ischemia and tolerance induction","volume":"36","author":"Dahl","year":"2000","journal-title":"Neurochem Int"},{"issue":"3","key":"10.3233\/JHD-180301_ref11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF02918905","article-title":"Inositol 1,4,5-trisphosphate binding sites in the brain: Regional distribution, characterization, and alterations in brains of patients with Parkinson\u2019s disease","volume":"1","author":"Kitamura","year":"1989","journal-title":"J Mol Neurosci"},{"issue":"2","key":"10.3233\/JHD-180301_ref12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0006-8993(89)90874-3","article-title":"Cerebellar [3H]inositol 1,4,5-trisphosphate binding is markedly decreased in human olivopontocerebellar atrophy","volume":"489","author":"Kish","year":"1989","journal-title":"Brain Res"},{"issue":"5","key":"10.3233\/JHD-180301_ref13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tins.2010.02.005","article-title":"Human ataxias: A genetic dissection of inositol triphosphate receptor (ITPR1)-dependent signaling","volume":"33","author":"Schorge","year":"2010","journal-title":"Trends Neurosci"},{"issue":"10","key":"10.3233\/JHD-180301_ref14","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/bies.20298","article-title":"The InsP3 receptor: Its role in neuronal physiology and neurodegeneration","volume":"27","author":"Banerjee","year":"2005","journal-title":"Bioessays"},{"issue":"5","key":"10.3233\/JHD-180301_ref15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JHD-180301_ref16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-1-4020-6191-2_11","article-title":"Inositol 1,4,5-tripshosphate receptor, calcium signalling and Huntington\u2019s disease","volume":"45","author":"Bezprozvanny","year":"2007","journal-title":"Subcell Biochem"},{"issue":"4","key":"10.3233\/JHD-180301_ref17","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1471-4159.1991.tb11440.x","article-title":"Reduced striatal [3H]inositol 1,4,5-trisphosphate binding in Huntington\u2019s disease","volume":"56","author":"Warsh","year":"1991","journal-title":"J Neurochem"},{"key":"10.3233\/JHD-180301_ref18","first-page":"175","article-title":"Second messenger systems in brains of patients with Parkinson\u2019s or Huntington\u2019s disease","volume":"60","author":"Tanaka","year":"1993","journal-title":"Adv Neurol"},{"issue":"2","key":"10.3233\/JHD-180301_ref19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0197-0186(98)00021-7","article-title":"Intracerebroventricular administration of quinolinic acid induces a selective decrease of inositol(1,4,5)-trisphosphate receptor in rat brain","volume":"33","author":"Haug","year":"1998","journal-title":"Neurochem Int"},{"issue":"2","key":"10.3233\/JHD-180301_ref20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0896-6273(03)00366-0","article-title":"Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1","volume":"39","author":"Tang","year":"2003","journal-title":"Neuron"},{"issue":"5","key":"10.3233\/JHD-180301_ref21","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1523\/JNEUROSCI.4411-08.2009","article-title":"Neuroprotective effects of inositol 1,4,5-trisphosphate receptor C-terminal fragment in a Huntington\u2019s disease mouse model","volume":"29","author":"Tang","year":"2009","journal-title":"J Neurosci"},{"issue":"1","key":"10.3233\/JHD-180301_ref22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1523\/JNEUROSCI.1038-15.2016","article-title":"Enhanced store-operated calcium entry leads to striatal synaptic loss in a Huntington\u2019s disease mouse model","volume":"36","author":"Wu","year":"2016","journal-title":"J Neurosci"},{"issue":"38","key":"10.3233\/JHD-180301_ref23","doi-asserted-by":"crossref","first-page":"E3966","DOI":"10.1073\/pnas.1409730111","article-title":"Aberrant calcium signaling by transglutaminase-mediated posttranslational modification of inositol 1,4,5-trisphosphate receptors","volume":"111","author":"Hamada","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.3233\/JHD-180301_ref24","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.neuron.2010.11.010","article-title":"Mechanism of ER stress-induced brain damage by IP(3) receptor","volume":"68","author":"Higo","year":"2010","journal-title":"Neuron"},{"issue":"3","key":"10.3233\/JHD-180301_ref25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.nbd.2009.08.012","article-title":"Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington\u2019s disease: Role in excitotoxicity","volume":"36","author":"Xifro","year":"2009","journal-title":"Neurobiol Dis"},{"issue":"4","key":"10.3233\/JHD-180301_ref26","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1523\/JNEUROSCI.06-04-00954.1986","article-title":"PCPP-260, a Purkinje cell-specific cyclic AMP-regulated membrane phosphoprotein of Mr 260,000","volume":"6","author":"Walaas","year":"1986","journal-title":"J Neurosci"},{"issue":"7","key":"10.3233\/JHD-180301_ref27","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1523\/JNEUROSCI.13-07-03051.1993","article-title":"Differential immunohistochemical localization of inositol 1,4,5- trisphosphate- and ryanodine-sensitive Ca2+ release channels in rat brain","volume":"13","author":"Sharp","year":"1993","journal-title":"J Neurosci"},{"issue":"7","key":"10.3233\/JHD-180301_ref28","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1073\/pnas.0409402102","article-title":"Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington\u2019s disease","volume":"102","author":"Tang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"30","key":"10.3233\/JHD-180301_ref29","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1523\/JNEUROSCI.1396-07.2007","article-title":"Dopaminergic signaling and striatal neurodegeneration in Huntington\u2019s disease","volume":"27","author":"Tang","year":"2007","journal-title":"J Neurosci"},{"issue":"12","key":"10.3233\/JHD-180301_ref30","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/prca.200800018","article-title":"Age-dependent gene expression profile and protein expression in a transgenic rat model of Huntington\u2019s disease","volume":"2","author":"Nguyen","year":"2008","journal-title":"Proteomics Clin Appl"},{"issue":"1-2","key":"10.3233\/JHD-180301_ref31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0006-8993(02)02550-7","article-title":"Altered neuronal nitric oxide synthase expression contributes to disease progression in Huntington\u2019s disease transgenic mice","volume":"939","author":"Deckel","year":"2002","journal-title":"Brain Res"},{"issue":"11","key":"10.3233\/JHD-180301_ref32","doi-asserted-by":"crossref","first-page":"7467","DOI":"10.1074\/jbc.274.11.7467","article-title":"Phosphorylation of the inositol 1,4,5-trisphosphate receptor by cyclic nucleotide-dependent kinases in vitro and in rat cerebellar slices in situ","volume":"274","author":"Haug","year":"1999","journal-title":"J Biol Chem"},{"issue":"2","key":"10.3233\/JHD-180301_ref33","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1523\/JNEUROSCI.23-02-00403.2003","article-title":"Modulation of type 1 inositol (1,4,5)-trisphosphate receptor function by protein kinase a and protein phosphatase 1alpha","volume":"23","author":"Tang","year":"2003","journal-title":"J Neurosci"},{"issue":"40","key":"10.3233\/JHD-180301_ref34","doi-asserted-by":"crossref","first-page":"42082","DOI":"10.1074\/jbc.M407389200","article-title":"Dopamine receptor-mediated Ca(2+) signaling in striatal medium spiny neurons","volume":"279","author":"Tang","year":"2004","journal-title":"J Biol Chem"},{"issue":"42","key":"10.3233\/JHD-180301_ref35","doi-asserted-by":"crossref","first-page":"39397","DOI":"10.1074\/jbc.M207059200","article-title":"Protein kinase A and two phosphatases are components of the inositol 1,4,5-trisphosphate receptor macromolecular signaling complex","volume":"277","author":"deSouza","year":"2002","journal-title":"J Biol Chem"},{"issue":"3","key":"10.3233\/JHD-180301_ref36","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0092-8674(95)90124-8","article-title":"Calcineurin associated with the inositol 1,4,5-trisphosphate receptor- FKBP12 complex modulates Ca2+ flux","volume":"83","author":"Cameron","year":"1995","journal-title":"Cell"},{"issue":"6","key":"10.3233\/JHD-180301_ref37","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.bbamcr.2008.12.003","article-title":"Regulation of inositol 1,4,5-trisphosphate-induced Ca2+ release by reversible phosphorylation and dephosphorylation","volume":"1793","author":"Vanderheyden","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.3233\/JHD-180301_ref38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1073\/pnas.0408352102","article-title":"Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum","volume":"102","author":"Oakes","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.3233\/JHD-180301_ref39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"issue":"12","key":"10.3233\/JHD-180301_ref40","doi-asserted-by":"crossref","first-page":"e1001242","DOI":"10.1371\/journal.pgen.1001242","article-title":"Continuous and periodic expansion of CAG repeats in Huntington\u2019s disease R6\/1 mice","volume":"6","author":"Mollersen","year":"2010","journal-title":"PLoS Genet"},{"issue":"3","key":"10.3233\/JHD-180301_ref41","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1471-4159.2010.06964.x","article-title":"Cerebellar lipid differences between R6\/1 transgenic mice and humans with Huntington\u2019s disease","volume":"115","author":"Denny","year":"2010","journal-title":"J Neurochem"},{"issue":"3","key":"10.3233\/JHD-180301_ref42","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.nbd.2005.12.014","article-title":"Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington\u2019s disease transgenic rats","volume":"22","author":"Kantor","year":"2006","journal-title":"Neurobiol Dis"},{"issue":"21","key":"10.3233\/JHD-180301_ref43","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1093\/hmg\/ddl394","article-title":"Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington\u2019s disease","volume":"15","author":"Nguyen","year":"2006","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.3233\/JHD-180301_ref44","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/hmg\/ddg075","article-title":"Transgenic rat model of Huntington\u2019s disease","volume":"12","author":"von H\u00f6rsten","year":"2003","journal-title":"Hum Mol Genet"},{"issue":"24","key":"10.3233\/JHD-180301_ref45","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J Neurosci"},{"key":"10.3233\/JHD-180301_ref46","first-page":"2179","article-title":"Transgenic animal models for study of the pathogenesis of Huntington\u2019s disease and therapy","volume":"9","author":"Chang","year":"2015","journal-title":"Drug Des Devel Ther"},{"issue":"12","key":"10.3233\/JHD-180301_ref47","doi-asserted-by":"crossref","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS One"},{"issue":"17","key":"10.3233\/JHD-180301_ref48","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1093\/hmg\/ddw212","article-title":"An enhanced Q175 knock-in mouse model of Huntington disease with higher mutant huntingtin levels and accelerated disease phenotypes","volume":"25","author":"Southwell","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-180301_ref49","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/7854_2013_245","article-title":"Transgenic rat models of Huntington\u2019s disease","volume":"22","author":"Carreira","year":"2015","journal-title":"Curr Top Behav Neurosci"},{"issue":"2","key":"10.3233\/JHD-180301_ref50","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bbr.2006.02.028","article-title":"Progressive deterioration of reaction time performance and choreiform symptoms in a new Huntington\u2019s disease transgenic ratmodel","volume":"170","author":"Cao","year":"2006","journal-title":"Behav Brain Res"},{"issue":"3","key":"10.3233\/JHD-180301_ref51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0014-5793(93)81345-Z","article-title":"Calcium-induced degradation of the inositol (1,4,5)-trisphosphate receptor\/Ca(2+)-channel","volume":"323","author":"Magnusson","year":"1993","journal-title":"FEBS Lett"},{"issue":"3","key":"10.3233\/JHD-180301_ref52","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0092-8674(82)90202-1","article-title":"Immunogenic structure of the influenza virus hemagglutinin","volume":"28","author":"Green","year":"1982","journal-title":"Cell"},{"issue":"4","key":"10.3233\/JHD-180301_ref53","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1021\/bi00571a022","article-title":"New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates","volume":"18","author":"Liu","year":"1979","journal-title":"Biochemistry"},{"issue":"4","key":"10.3233\/JHD-180301_ref54","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/29.4.6166661","article-title":"Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures","volume":"29","author":"Hsu","year":"1981","journal-title":"J Histochem Cytochem"},{"key":"10.3233\/JHD-180301_ref55","unstructured":"Paxinos G , Watson C , The Rat Brain in Stereotactic Coordinates. 6 ed. Amsterdam: Elsevier Academic Press.; 2007."},{"issue":"5895","key":"10.3233\/JHD-180301_ref56","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/301069a0","article-title":"A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions","volume":"301","author":"Walaas","year":"1983","journal-title":"Nature"},{"issue":"24","key":"10.3233\/JHD-180301_ref57","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1073\/pnas.82.24.8780","article-title":"The neostriatal mosaic: Compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey","volume":"82","author":"Gerfen","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.3233\/JHD-180301_ref58","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/syn.890020507","article-title":"Quantitation of nerve terminal populations: Synaptic vesicle-associated proteins as markers for synaptic density in the rat neostriatum","volume":"2","author":"Walaas","year":"1988","journal-title":"Synapse"},{"issue":"17","key":"10.3233\/JHD-180301_ref59","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1097\/00001756-200011270-00032","article-title":"N-Acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington\u2019s disease mice","volume":"11","author":"van Dellen","year":"2000","journal-title":"Neuroreport"},{"issue":"1","key":"10.3233\/JHD-180301_ref60","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/syn.890020112","article-title":"Purification and characterization of PCPP- A Purkinje cell-enriched cyclic AMP-regulated membrane phosphoprotein of Mr 260,000","volume":"2","author":"Weeks","year":"1988","journal-title":"Synapse"},{"issue":"1","key":"10.3233\/JHD-180301_ref61","first-page":"84","article-title":"DARPP-32, a dopamine- and adenosine 3\u2019:5\u2019-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions","volume":"4","author":"Walaas","year":"1984","journal-title":"I. Regional and cellular distribution in the rat brain. J Neurosci"},{"issue":"3","key":"10.3233\/JHD-180301_ref62","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1602\/neurorx.2.3.447","article-title":"The use of the R6 transgenic mouse models of Huntington\u2019s disease in attempts to develop novel therapeutic strategies","volume":"2","author":"Li","year":"2005","journal-title":"NeuroRx"},{"key":"10.3233\/JHD-180301_ref63","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fncel.2018.00381","article-title":"Huntingtin-associated protein 1A regulates store-operated calcium entry in medium spiny neurons from transgenic YAC128 mice, a model of Huntington\u2019s disease","volume":"12","author":"Czeredys","year":"2018","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"10.3233\/JHD-180301_ref64","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00429-012-0427-0","article-title":"Altered diffusion tensor imaging measurements in aged transgenic Huntington disease rats","volume":"218","author":"Antonsen","year":"2013","journal-title":"Brain Struct Funct"},{"issue":"36","key":"10.3233\/JHD-180301_ref65","first-page":"21933","article-title":"Phosphorylation of the inositol 1,4,5-trisphosphate receptor","volume":"271","author":"Komalavilas","year":"1996","journal-title":"Cyclic GMP-dependent protein kinase mediates cAMP and cGMP dependent phosphorylation in the intact rat aorta. J Biol Chem"},{"issue":"1","key":"10.3233\/JHD-180301_ref66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(97)00391-0","article-title":"Autoradiographic characterization of [3H]cGMP binding sites in the rat brain","volume":"763","author":"Bonkale","year":"1997","journal-title":"Brain Res"},{"issue":"1","key":"10.3233\/JHD-180301_ref67","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.expneurol.2012.04.015","article-title":"Disruption of Purkinje cell function prior to huntingtin accumulation and cell loss in an animal model of Huntington disease","volume":"236","author":"Dougherty","year":"2012","journal-title":"Exp Neurol"},{"key":"10.3233\/JHD-180301_ref68","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.expneurol.2012.11.015","article-title":"Purkinje cell dysfunction and loss in a knock-in mouse model of Huntington disease","volume":"240","author":"Dougherty","year":"2013","journal-title":"Exp Neurol"},{"issue":"12","key":"10.3233\/JHD-180301_ref69","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1016\/j.neurobiolaging.2014.06.010","article-title":"Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6\/2 Huntington mice","volume":"35","author":"Ooms","year":"2014","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.3233\/JHD-180301_ref70","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0014-4886(84)90162-6","article-title":"Reduced Purkinje cell density in Huntington\u2019s disease","volume":"85","author":"Jeste","year":"1984","journal-title":"Exp Neurol"},{"issue":"2","key":"10.3233\/JHD-180301_ref71","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1750-3639.2012.00629.x","article-title":"Degeneration of the cerebellum in Huntington\u2019s disease (HD): Possible relevance for the clinical picture and potential gateway to pathological mechanisms of the disease process","volume":"23","author":"Rub","year":"2013","journal-title":"Brain Pathol"},{"issue":"1","key":"10.3233\/JHD-180301_ref72","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0022-510X(81)90049-6","article-title":"Cerebellar atrophy in Huntington\u2019s disease","volume":"50","author":"Rodda","year":"1981","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.3233\/JHD-180301_ref73","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0730-4862(84)90012-X","article-title":"Cerebellum and brain stem atrophy in a child with Huntington\u2019s chorea","volume":"8","author":"Hattori","year":"1984","journal-title":"Comput Radiol"},{"issue":"13","key":"10.3233\/JHD-180301_ref74","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/mds.25984","article-title":"Cerebellar abnormalities in Huntington\u2019s disease: A role in motor and psychiatric impairment?","volume":"29","author":"Rees","year":"2014","journal-title":"Mov Disord"},{"issue":"2","key":"10.3233\/JHD-180301_ref75","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/72101","article-title":"Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1","volume":"3","author":"Lin","year":"2000","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.3233\/JHD-180301_ref76","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/14734220510007914","article-title":"The wide spectrum of spinocerebellar ataxias (SCAs)","volume":"4","author":"Manto","year":"2005","journal-title":"Cerebellum"},{"issue":"7","key":"10.3233\/JHD-180301_ref77","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s11064-010-0393-y","article-title":"Role of inositol 1,4,5-trishosphate receptors in pathogenesis of Huntington\u2019s disease and spinocerebellar ataxias","volume":"36","author":"Bezprozvanny","year":"2011","journal-title":"Neurochem Res"},{"issue":"5","key":"10.3233\/JHD-180301_ref78","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.bbamcr.2010.11.023","article-title":"The IP(3) receptor-mitochondria connection in apoptosis and autophagy","volume":"1813","author":"Decuypere","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.3233\/JHD-180301_ref79","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.molcel.2009.10.021","article-title":"GM1-ganglioside accumulation at the mitochondria-associated ER membranes links ER stress to Ca(2+)-dependent mitochondrial apoptosis","volume":"36","author":"Sano","year":"2009","journal-title":"Mol Cell"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-180301","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:50:48Z","timestamp":1777452648000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-180301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,27]]},"references-count":79,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jhd-180301","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,27]]}}}